supply Medetomidine hcl powder CAS 86347-15-1
supply Medetomidine hcl powder CAS 86347-15-1
factory
certificate
Home > Pharmaceutical intermediates

supply Medetomidine hcl powder CAS 86347-15-1

Related Attributes


Product details

In vivo studies of Medetomidine hcl.

In anesthetized rats, medetomidine (1-100 μg/kg, intravenous) caused a dose-dependent transient decrease in blood pressure and heart rate. In myelospondylotomized rats, medetomidine showed potent vasopressor (PD50 1.7 μg/kg) and sympathoinhibitory (ID50 1.6 μg/kg) effects without affecting basal heart rate.

Medetomidine caused dose-dependent sedation, loss of the forward reflex at high doses (>100 μg/kg), and decreased body temperature. Medetomidine caused a decrease in the turnover of biogenic amines in the brain, a dose-dependent inhibition of norepinephrine (NE) turnover, inhibition of brain dopamine turnover at high doses, and a decrease in serotonin turnover.

Medetomidine hcl Medetomidine hcl powder

WHY CHOOES US?

WHY CHOOES US

OUR CERTIFICATE

OUR CERTIFICATE

CUSTOM PROCESS

CUSTOM PROCESS

OUR PACKAGE

OUR PACKAGE

OUR EXHIBITION

OUR EXHIBITION

OUR FACTORY

OUR FACTORY

Shipping

Shipping

Prev: Raw Materials powder Strontium ranelate Next: Pure Natural Water Soluble 98% wild yam root extract powder

Pharmaceutical Intermediate manufacturers

sales18@interlgroup.com

©2022 Xi'an Henrikang Biotech Co., Ltd.,

HomeHome
EmailE-mail
ProductBooking